Evaluation of the Effectiveness of Risk Minimisation Measures: A Survey among Health Care Professionals to Assess their Knowledge and Attitudes on Prescribing Conditions of Instanyl® in France and the Netherlands

16/06/2015
29/03/2024
EU PAS number:
EUPAS9924
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Instanyl-5001- Protocol revised-FINAL-2015-02-06-V3

English (928.64 KB - PDF) View document
Study results
Study results

Instanyl-5001 Study Report 24 Apr 2016

English (3.02 MB - PDF) View document
Study report
Other information